NasdaqCM - Nasdaq Real Time Price USD
Lexaria Bioscience Corp. (LEXX)
1.5600
-0.0300
(-1.88%)
As of 1:30:28 PM EDT. Market Open.
Breakdown
TTM
8/31/2024
8/31/2023
8/31/2022
8/31/2021
Operating Cash Flow
-7,381.6720
-4,959.0030
-5,881.2370
-4,879.3390
-3,989.6780
Investing Cash Flow
-157.2870
-188.6050
-169.6100
-180.6400
193.8800
Financing Cash Flow
9,400.1140
10,315.2070
1,589.7310
-44.6000
13,419.8460
End Cash Position
6,566.5540
6,499.8850
1,352.1020
5,813.2180
10,917.7970
Income Tax Paid Supplemental Data
--
10.0420
8.2140
4.7820
16.2970
Capital Expenditure
-157.2870
-188.6050
-169.6100
-180.6400
-79.4930
Issuance of Capital Stock
4,357.1130
4,208.7310
1,589.7310
--
9,471.4970
Repayment of Debt
--
--
--
-44.6000
-66.6940
Free Cash Flow
-7,538.9590
-5,147.6080
-6,050.8470
-5,059.9790
-4,069.1710
8/31/2021 - 1/12/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BCTXW BriaCell Therapeutics Corp.
0.1700
+36.06%
LIXT Lixte Biotechnology Holdings, Inc.
1.2800
-2.29%
RNTX Rein Therapeutics Inc.
1.7900
-1.65%
IPHA Innate Pharma S.A.
1.9700
0.00%
LTRN Lantern Pharma Inc.
3.6500
-2.14%
INTS Intensity Therapeutics, Inc.
0.9678
-25.55%
KAPA Kairos Pharma, Ltd.
0.8475
-1.43%
TRAW Traws Pharma, Inc.
1.5100
+2.72%
SPRB Spruce Biosciences, Inc.
0.1330
+0.08%
UBX Unity Biotechnology, Inc.
0.9801
-0.60%